Program Description:
|
Most people think about investment as a risky venture, but it is not always so. There is the industry that is not effected by a recent market downturn and economic slowdown, it’s a biotech industry. The trend of increased healthcare spending and technology advancements, and the unmet medical needs for cures and treatments will continue to provide the biotech sector with growth and advancements, as well as lucrative investment opportunities. Take Intuitive Surgical (ISRG - NASDAQ), for example. This company makes the robotic da Vinci surgical systems for use in urologic, cardiothoracic, gynecologic, and general surgeries.
Sales at ISRG have exploded from $26 million in 2008 to over $524 million today. In fact, the stock is up 5,400% since the start of 2008! And with Baby Boomers getting surgeries in record numbers, medical device companies like Intuitive Surgical are going to continue profiting accordingly.
Drug companies also stand to make a fortune as Baby Boomers get older and need more health care. How much? Try $2.2 TRILLION by 2014. That's how much Americans will spend on health care. With a market that large, being bullish on biotech is a no-brainer. Take a look at some of the returns posted by biotech stocks:
Amgen...............+59,000%
Gilead Sciences....+3,500%
Biogen IDEC........+2,329%
Celgene..............+9,030%
IDEXX Labs.........+3,300%
Still, there's a second, much less-heralded benefit to investing in biotech stocks and funds right now: Drugs are recession proof. They have no exposure to sub prime and housing concerns… And no matter what happens with the economy, people still buy medication. Period. W've recently discovered a small company that's about to become a blockbuster in the biotech industry. The stock is up 60% since November… and I think it's an easy double or even triple in 2010, as its drugs continue through the testing and approval process. Biotechinvestmentfund brings together all the elements required to make knowledgeable and successful investments by utilizing our Executive and Advisory Network. This team consists of practicing physicians, biotech researchers and scientists, successful biotech entrepreneurs, and experienced biotech investors. |
EN 
DE | NEWSLETTER
100%
